Discover 1,849 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
AstraZeneca
Location:
Code:
NCT06307665
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
BDA MDI
AS MDI
Sponsor:
AbbVie
Location:
Code:
NCT04064827
Conditions
Chronic Kidney Disease (CKD)
Secondary Hyperparathyroidism (SHPT)
Eligibility Criteria
Sex: All
Age: 0 - 9
Healthy Volunteers: Not accepted
Interventions
Paricalcitol
Sponsor:
Edwards Lifesciences
Location:
Code:
NCT05172973
Conditions
Aortic Valve Insufficiency
Aortic Valve Stenosis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
SAPIEN X4 THV
Sponsor:
Takeda
Location:
Code:
NCT04844073
Conditions
Squamous Cell Cancer of Head and Neck (SCCHN)
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAK-186
Sponsor:
Kowa Research Institute, Inc.
Location:
Code:
NCT05327127
Conditions
NASH
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
K-877-ER
CSG452
Placebo
Sponsor:
BioNTech SE
Location:
Code:
NCT04813627
Conditions
Colorectal Cancer Stage II
Colorectal Cancer Stage III
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Regular blood sample collection for ctDNA assessment
Sponsor:
Priovant Therapeutics, Inc.
Location:
Code:
NCT06431373
Conditions
Uveitis, Posterior
Uveitis, Intermediate
Uveitis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Brepocitinib PO QD
Placebo PO QD
Sponsor:
Dennis M. McNamara, MD, MS
Location:
Code:
NCT05180773
Conditions
Peripartum Cardiomyopathy, Postpartum
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bromocriptine
Placebo
Guideline Directed Medical Therapy for Heart Failure (GDMT)
Rivaroxaban
Second Placebo
Sponsor:
Amgen
Location:
Code:
NCT06660173
Conditions
Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Maridebart Cafraglutide
Placebo
Sponsor:
Amgen
Location:
Code:
NCT05975073
Conditions
MTAP-null Non-Small-Cell Lung Cancer
MTAP-null Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMG 193
IDE397
Sponsor:
Pfizer
Location:
Code:
NCT04173273
Conditions
Crohn's Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Etrasimod
Placebo
Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.
These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.
Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.
In Dallas, clinical trials encompass a broad spectrum of medical conditions and diseases, underscoring the city’s role as a leading center for innovative research.
Cardiovascular clinical trials in Dallas address a variety of heart-related conditions, including coronary artery disease, heart failure, and hypertension. Research focuses on pioneering therapies such as new-generation stents, novel anticoagulants, and innovative heart failure treatments.
Medical device clinical trials are also commonly explored, like implantable cardioverter-defibrillators (ICDs) and ventricular assist devices (VADs), as well as lifestyle interventions and surgical techniques aimed at improving cardiovascular health and reducing the incidence of heart disease.
Dallas is at the forefront of cancer research, with trials investigating multiple types of malignancies including breast cancer, prostate cancer, lung cancer, and leukemia. Researchers are testing cutting-edge therapies such as CAR-T cell therapy, which involves engineering a patient’s own immune cells to target cancer, and new immune checkpoint inhibitors that boost the body’s ability to fight cancer.
Trials also focus on personalized medicine approaches, where treatments are tailored based on the genetic profile of both the patient and the tumor, aiming to enhance treatment efficacy and minimize side effects.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Trials in Dallas for neurological conditions include research on Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS), and epilepsy. They may involve testing new pharmacological agents that target specific disease mechanisms, experimental treatments such as stem cell therapy or gene editing, and novel approaches like deep brain stimulation or cognitive rehabilitation programs.
The city’s research efforts are driven by the increasing prevalence of neurodegenerative disorders and the need for more effective treatments to manage these complex conditions.
Clinical trials in Dallas have a broad focus on managing diabetes and endocrine disorders, including type 1 and type 2 diabetes, metabolic syndrome, thyroid disorders, and polycystic ovary syndrome (PCOS).
Research often explores new insulin delivery systems, such as smart insulin pens and continuous glucose monitors, as well as innovative medications that address insulin resistance and hormonal imbalances. Trials also include studies on lifestyle interventions and weight management to improve long-term outcomes for individuals with diabetes and related conditions.
Many clinical trials in Dallas target autoimmune diseases like rheumatoid arthritis, lupus, and dermatological conditions such as psoriasis. Researchers are evaluating new biologic agents that specifically inhibit immune system components involved in these diseases, as well as combination therapies that aim to enhance efficacy and reduce the need for corticosteroids.
These trials also investigate novel approaches to manage symptoms and improve quality of life for patients with chronic autoimmune conditions.
Trials for respiratory conditions in Dallas include studies on asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Research efforts focus on developing new inhaled medications, such as biologics that target specific inflammatory pathways in asthma, and advanced drug delivery systems that improve medication adherence and effectiveness.
Trials in infectious diseases cover a wide range of conditions, including HIV, hepatitis C, and influenza. Research includes the development of new antiviral medications, vaccines for emerging and re-emerging infections, and strategies for improving treatment adherence and outcomes. Trials may also investigate new diagnostic tools and treatment protocols to enhance disease management and prevention.
In Dallas, clinical trials are governed by a comprehensive framework that ensures ethical and regulatory compliance. Federal oversight is provided by the U.S. Food and Drug Administration (FDA), which sets standards for trial design, conduct, and reporting. All studies must be reviewed and approved by an Institutional Review Board (IRB), ensuring the protection of participant rights and adherence to ethical guidelines.
Researchers in Dallas are required to follow Good Clinical Practice (GCP) standards, which include strict protocols for data management, participant recruitment, and reporting adverse events. State-specific regulations from the Texas Medical Board also apply, alongside federal and privacy laws such as the Health Insurance Portability and Accountability Act (HIPAA), which safeguard participants' personal health information. The informed consent process is also crucial, providing participants with detailed information about the study and their rights.
Joining a clinical trial provides the exclusive benefit of accessing novel treatments and therapies before they become widely available. Participants also benefit from exceptional care by leading healthcare professionals, who provide thorough monitoring and customized support throughout the study.
Participating in clinical trials is essential for progressing medical research and may lead to groundbreaking advancements in treatments or preventative care. By volunteering in a trial, individuals not only gain early access to innovative medical solutions but also play a key role in advancing scientific knowledge, thereby contributing to future improvements in healthcare for others.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: